Clinical trial
Applying Directly Observed Therapy to Hydroxyurea to Realize Effectiveness
NCT06264700 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Applying Directly Observed Therapy to Hydroxyurea to Realize Effectiveness
- Lead sponsor
- Nationwide Children's Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 11, 2024
- Completion date
- July 23, 2026
- Enrollment
- 60 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease